BETA


1999/2095(COS) Action to combat drugs: action plan 2000-2004

Progress: Procedure completed

RoleCommitteeRapporteurShadows
Lead LIBE GIANNAKOU Marietta (icon: PPE-DE PPE-DE)
Committee Opinion DEVE
Committee Opinion AFET
Committee Opinion BUDG
Committee Opinion ITRE CORBEY Dorette (icon: PES PES)
Committee Opinion EMPL
Lead committee dossier:
Legal Basis:
RoP 142

Events

2005/02/14
   EC - Follow-up document
Details

PURPOSE : to present the Commission’s EU Drugs Action Plan for 2005-2008 with a view to significantly reducing the prevalence of drug use among the EU population and to reduce the social harm and health damage it causes in societies.

CONTENT : in December 2004, the European Council endorsed the EU Drug Strategy (2005-2012) which sets the framework, objectives and priorities for two consecutive four-year Action Plans to be brought forward by the Commission. This Strategy is an integral part of the multiannual programme “The Hague Programme” for strengthening freedom, security and justice in the EU which states that an optimal level of protection of the area of freedom, security and justice requires multi-disciplinary and concerted action both at EU level and national level.

The current drugs situation in Europe can be summarised as follows:

- increasing numbers demanding treatment for cocaine use;

- signs of heavy cannabis use among teenagers;

- increase in ecstasy consumption. The EU remains one of the world’s most important areas for the production of ecstasy;

- 2.1 million problematic drug users in the EU25;

- HIV/Aids is declining in some countries but the risk of epidemic spread remains high. Deep concern surrounds the continuing HIV epidemic in some of the new EU Member States and their bordering countries.

This Action Plan transposes the general objectives contained in the EU Drugs Strategy 2005-2012 into concrete actions.

These include general policy measures, specific programmes aimed at the prevention of drug use amongst young people, in the workplace and in recreational settings as well as measures for improving access to treatment programmes.

A set of measurable assessment tools and indicators has been introduced for each action in order to enable proper evaluation.

The Strategy has a number of major objectives:

- to achieve a high level of health protection, well-being and social cohesion by complementing the Member States’ action in preventing and reducing drug use, dependence and drug-related harms to health and society;

- with due regard for the EU’s achievements and values in terms of fundamental rights and freedoms, to ensure a high level of security for the general public by taking action against drugs production, cross-border trafficking in drugs and diversion of precursors and by intensifying preventive action against drug-related crime through effective cooperation embedded in a joint approach;

- to strengthen the EU’s coordination mechanisms to ensure that action taken at national, regional and international levels is complementary and contributes to the effectiveness of drug policies within the EU and in its relations with other international partners. The latter calls for a more clearly identifiable European position in international fora such as the UN and its specialised agencies, reflecting the EU’s dominant position as a donor in this area.

The Strategy concentrates on the two major dimensions of drugs policy, demand reduction and supply reduction. It also covers a number of cross-cutting themes: international cooperation, research, information and evaluation.

The Action Plan proposed by the Commission takes account of its Final Evaluation of the EU Drug Strategy and EU Action Plan on Drugs (2000–2004) (refer to the summary of 22/10/2004). It targets in particular those areas that the evaluation highlighted as needing further progress. It reiterates a number of essential objectives that were not reached under the previous Action Plan. The Commission has also carried out an initial consultation of civil society on future policy through a dedicated web site. Such consultation will be significantly expanded by the Commission during the course of the Action Plan to include a wide range of representatives of civil society across the EU in a dialogue on how best to deal with drugs issues.

Lastly, the Commission will carry out an impact assessment in 2008 in view of proposing a second Action Plan for 2009-2012. A final evaluation of the Strategy and the Action Plans will be carried out by the Commission in 2012.

2005/02/14
   EC - Follow-up document
Details

COMMISSION’S IMPACT ASSESSMENT

1. PROBLEM IDENTIFICATION :

The drugs phenomenon is one of the major concerns of European citizens. Tackling drugs is a top priority of the European Union in view of the high levels of drug misuse, trafficking, drug-related crime, health problems and social exclusion. Just under1% of the European adult population is considered to comprise problem drug-users. Moreover, drug consumption amongst young people has reached historically high levels.

For more information regarding the context of this problem, please refer to the complementary summary of the Communication ( COM( 2005)0045) on an EU Drugs Action Plan (2005-2008).

2. OBJECTIVE :

The ultimate aim of any EU action in the field of drugs is to significantly reduce the prevalence of drug use among the population and to reduce the social harm and health damage caused by the use of drugs, building on the outcome of the former EU Drugs Action Plan (2000-2004).

3. POLICY OPTIONS AND IMPACTS :

In order to tackle the drugs issue in the EU and to achieve the objectives outlined above, several options are envisaged:

3.1 - Option A : Actions in the field of drugs are left exclusively to the Member States : drugs are a problem that knows no national boundaries. In the case that actions in the field of drugs were purely taken at national level, the fight against drugs would be as difficult as in the case of other global threats such as terrorism or organised crime. Moreover, the implementation of 25 national policies and strategies reflecting different complex social and cultural models would raise important difficulties for the freedom of movement of people and goods. This paper states that the drugs issue is a world-wide phenomenon which requires a coordinated and integrated approach. What is at stake here is the protection of the values of freedom, security and justice which are the very basis of European society. Therefore, the only way to deal with this is to create European added value.

Due to the reasons outlined above, the European Council endorsed in 2000 an Action Plan providing a common framework for policymaking calling for a balanced, coordinated and integrated approach.

3.2 - Option B : The former Action Plan 2000-2004 is renewed for another 5 year period : the Action Plan 2000-2004 was divided into five sections: i ) co-ordination, ii) information and evaluation, iii) drug demand reduction and prevention of drug use and drug-related crime, iv) supply reduction and (v) international co-operation.

The conclusions of the final evaluation on the EU Drugs Strategy and Action Plan on Drugs were presented by the Commission in October 2004:

- a large part of the actions set out in the EU Action Plan on Drugs have been implemented or are in some stage of being implemented;

- the EU Drugs Strategy and Action Plan have been taken as a central reference point for action and have provided a framework for drug-related activities and initiatives at national and EU level;

- almost all Member States have adopted a national drugs strategy or action plan. Among the elements in these national drugs strategies and action plans, are common patterns with the EU approach, as outlined in the EU Drugs Strategy and Action Plan;

- there can be little doubt that the implementation of the actions in the Action Plan has contributed to the achievement, to a greater or lesser extent, of the 11 aims of the EU Drugs Strategy;

- the available information does not suggest that the availability of drugs has been reduced substantially;

- a number of important initiatives have also been taken to combat money laundering.

The final evaluation proposes that the future EU Drugs Strategy should contain clear and precise objectives and priorities that can be translated into operational indicators and actions in future Action Plans.

3.3 - Option C : a new Action Plan is presented, building on the main lessons from the final evaluation of the EU Action Plan 2000-2004 and in connection with the new Drugs Strategy 2005-2012: the new EU Strategy on Drugs 2005-2012 has two general aims that can be summed up as follows: the EU aims to achieve a high level of health protection, well-being and social cohesion by complementing the Member States’ action in preventing and reducing drug use, dependence and drug-related harm to health and society; the EU and its Member States aim to ensure a high level of security for the general public by taking action against drugs production, cross-border drug trafficking and by intensifying preventive action against drug-related crime, through effective cooperation embedded in a joint approach.

Clear and measurable assessment tools and indicators have been introduced, to the extent possible, to enable proper evaluation.

3.4 - Option D : a EU policy on drugs is proposed: 71% of Europeans believe that decisions on drugs should be taken at EU level. EU added value is most visible on issues like the fight against drug trafficking, precursor control and action against money laundering. Given the absence of an overall legal basis for a common EU drugs policy and in view of national sensitivities in this matter, the main aim can only be to achieve a coordinated policy, with due regard to the principles of subsidiarity and proportionality.

CONCLUSION : On the basis of lessons learned from the final evaluation, it was decided, in the draft Commission proposal, to discard options A, B and D and to present an improved new Action Plan (option C).

4. FOLLOW- UP : With a view to proposing a second Action Plan for the period 2009-2012, the Commission will organise an impact assessment in 2008. During 2009-2012, annual progress reviews will continue to be drawn up by the Commission. In 2012, the Commission will organise an overall evaluation of the EU Drugs Strategy and Action Plans. Moreover, the Commission launched, via the internet, an initial public consultation on the Action Plan which came to an end on 8 November 2004 which will be the subject of a Green Paper.

2004/10/22
   EC - Follow-up document
Details

Since 2000, the EU has adopted a Strategy and an Action Plan aimed at reducing both the demand for and supply of drugs in the European Union. This Communication presents the results of the final evaluation of the Strategy and Action Plan. As well as assessing the implementation of the Action Plan it also lays the foundation for the future EU drugs policy on the basis of what lessons have been learned from the present process.

The actual evaluation of the Action Plan was undertaken in April 2003 and involved input from Commission representatives, Member States the EMCDDA and Europol. Drug policy impact evaluation is still in its infancy phase and the lack of precise and quantifiable operation objects does not make the task simple. Nevertheless certain trends have been identified, indicating which activities should be prioritised in the future.

The evaluation process has established that around 95% of the actions set out in the EU plan on drugs have been implemented or are being implemented. Further, there can be little doubt that the implementation of the Action Plan has contributed to the achievement of the 11 aims specified in the EU Drugs Strategy. In terms of the target set for the reduction of drug use, the Communications notes that no strong evidence exists to suggest that drug use, especially amongst young people is decreasing. However, some of the data does point to evidence of a levelling off in the upward trend in drug use prevalence, - albeit that drug use is at historically high levels. Some of the results obtained from the evaluation process show that many of the EU targets set have acted as a catalyst for a number of EU level initiatives, which have strengthened law enforcement measures against drug trafficking and supply. Similarly, a number of important initiatives have been taken to combat money laundering with a number of Member States participating in important initiatives to combat the diversion of precursors, such as the European Joint Unit on Precursors.

Regarding a future strategy, the Commission suggest that a future EU Drugs Strategy should contain clear and precise objectives and priorities, which are easily translated into operational indicators and actions. Responsibilities and deadlines for implementation should be clearly defined. Continued progress should be made regarding drug availability, quality and comparability. In order to create a smooth transition the European Commission will present, in the course of 2005, proposals for a new Action Plan, set to last from 2005-2008. The objectives of the new Drugs Strategy and Action Plan should be reflected in the Multi-annual Programme for the area of freedom, security and justice.

2002/11/04
   EC - Follow-up document
2001/06/08
   EC - Follow-up document
2001/03/15
   CSL - Debate in Council
Documents
2001/03/15
   CSL - Council Meeting
2000/07/07
   Final act published in Official Journal
1999/11/19
   EP - Text adopted by Parliament, single reading
1999/11/19
   EP - Decision by Parliament
Documents
1999/11/19
   EP - End of procedure in Parliament
1999/11/18
   CofR - Committee of the Regions: opinion
1999/11/18
   EP - Debate in Parliament
1999/11/15
   EP - Committee report tabled for plenary, single reading
1999/11/15
   EP - Vote in committee
1999/11/14
   EP - Committee report tabled for plenary
Documents
1999/10/04
   CSL - Debate in Council
Documents
1999/10/04
   CSL - Council Meeting
1999/10/04
   EP - CORBEY Dorette (PES) appointed as rapporteur in ITRE
1999/09/13
   EP - Committee referral announced in Parliament
1999/07/29
   EP - GIANNAKOU Marietta (PPE-DE) appointed as rapporteur in LIBE
1999/05/26
   EC - Non-legislative basic document
1999/05/25
   EC - Non-legislative basic document published

Documents

History

(these mark the time of scraping, not the official date of the change)

docs/0
date
1999-05-26T00:00:00
docs
summary
type
Non-legislative basic document
body
EC
docs/0
date
1999-10-13T00:00:00
docs
title: PE231.809
type
Committee draft report
body
EP
docs/1
date
1999-11-03T00:00:00
docs
title: PE231.699/DEF
committee
ITRE
type
Committee opinion
body
EP
docs/2
date
1999-11-04T00:00:00
docs
title: PE231.809/AM
type
Amendments tabled in committee
body
EP
docs/3
date
1999-11-19T00:00:00
docs
summary
type
Text adopted by Parliament, single reading
body
EP
docs/3
date
1999-11-11T00:00:00
docs
title: PE231.809/AMC
type
Amendments tabled in committee
body
EP
docs/3/docs/1/url
Old
https://eur-lex.europa.eu/JOHtml.do?uri=OJ:C:2000:189:SOM:EN:HTML
New
https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=OJ:C:2000:189:TOC
docs/5
date
2002-11-04T00:00:00
docs
summary
type
Follow-up document
body
EC
docs/5/docs/0/url
Old
http://www.europarl.europa.eu/RegData/docs_autres_institutions/commission_europeenne/com/2002/0599/COM_COM(2002)0599_EN.pdf
New
http://www.europarl.europa.eu/registre/docs_autres_institutions/commission_europeenne/com/2002/0599/COM_COM(2002)0599_EN.pdf
docs/6
date
1999-11-19T00:00:00
docs
summary
type
Text adopted by Parliament, single reading
body
EP
docs/6
date
2004-10-22T00:00:00
docs
summary
type
Follow-up document
body
EC
docs/6/docs/0/url
Old
http://www.europarl.europa.eu/RegData/docs_autres_institutions/commission_europeenne/com/2004/0707/COM_COM(2004)0707_EN.pdf
New
http://www.europarl.europa.eu/registre/docs_autres_institutions/commission_europeenne/com/2004/0707/COM_COM(2004)0707_EN.pdf
docs/7
date
2005-02-14T00:00:00
docs
summary
type
Follow-up document
body
EC
docs/7/docs/0/url
Old
http://www.europarl.europa.eu/registre/docs_autres_institutions/commission_europeenne/com/2005/0045/COM_COM(2005)0045_EN.pdf
New
http://www.europarl.europa.eu/RegData/docs_autres_institutions/commission_europeenne/com/2005/0045/COM_COM(2005)0045_EN.pdf
docs/8
date
2002-11-04T00:00:00
docs
summary
type
Follow-up document
body
EC
docs/9
date
2004-10-22T00:00:00
docs
summary
type
Follow-up document
body
EC
docs/10
date
2005-02-14T00:00:00
docs
summary
type
Follow-up document
body
EC
events/0/date
Old
1999-05-26T00:00:00
New
1999-05-25T00:00:00
events/4/date
Old
1999-11-15T00:00:00
New
1999-11-14T00:00:00
docs/4/docs/0/url
Old
http://www.europarl.europa.eu/doceo/document/A-5-1999-0063_EN.html
New
https://www.europarl.europa.eu/doceo/document/A-5-1999-0063_EN.html
docs/5/docs/0/url
Old
https://dm.cor.europa.eu/CORDocumentSearch/Pages/redresults.aspx?k=(documenttype:AC)(documentnumber:0292)(documentyear:1999)(documentlanguage:EN)
New
https://dmsearch.cor.europa.eu/search/public?k=(documenttype:AC)(documentnumber:0292)(documentyear:1999)(documentlanguage:EN)
docs/6
date
1999-11-19T00:00:00
docs
summary
type
Text adopted by Parliament, single reading
body
EP
docs/6
date
1999-11-19T00:00:00
docs
summary
type
Text adopted by Parliament, single reading
body
EP
docs/9/docs/0/url
Old
http://www.europarl.europa.eu/registre/docs_autres_institutions/commission_europeenne/com/2004/0707/COM_COM(2004)0707_EN.pdf
New
http://www.europarl.europa.eu/RegData/docs_autres_institutions/commission_europeenne/com/2004/0707/COM_COM(2004)0707_EN.pdf
docs/10/docs/0/url
Old
http://www.europarl.europa.eu/RegData/docs_autres_institutions/commission_europeenne/com/2005/0045/COM_COM(2005)0045_EN.pdf
New
http://www.europarl.europa.eu/registre/docs_autres_institutions/commission_europeenne/com/2005/0045/COM_COM(2005)0045_EN.pdf
docs/11/docs/0/url
Old
http://www.europarl.europa.eu/registre/docs_autres_institutions/commission_europeenne/sec/2005/0216/COM_SEC(2005)0216_EN.pdf
New
http://www.europarl.europa.eu/RegData/docs_autres_institutions/commission_europeenne/sec/2005/0216/COM_SEC(2005)0216_EN.pdf
events/1/type
Old
Committee referral announced in Parliament, 1st reading/single reading
New
Committee referral announced in Parliament
events/3/type
Old
Vote in committee, 1st reading/single reading
New
Vote in committee
events/4
date
1999-11-15T00:00:00
type
Committee report tabled for plenary
body
EP
docs
url: https://www.europarl.europa.eu/doceo/document/A-5-1999-0063_EN.html title: A5-0063/1999
events/4
date
1999-11-15T00:00:00
type
Committee report tabled for plenary, single reading
body
EP
docs
url: http://www.europarl.europa.eu/doceo/document/A-5-1999-0063_EN.html title: A5-0063/1999
events/5/docs/0/url
Old
http://www.europarl.europa.eu/sides/getDoc.do?secondRef=TOC&language=EN&reference=19991118&type=CRE
New
https://www.europarl.europa.eu/doceo/document/EN&reference=19991118&type=CRE
events/6
date
1999-11-19T00:00:00
type
Decision by Parliament
body
EP
docs
url: https://www.europarl.europa.eu/doceo/document/TA-5-1999-0121_EN.html title: T5-0121/1999
summary
events/6
date
1999-11-19T00:00:00
type
Decision by Parliament, 1st reading/single reading
body
EP
docs
url: http://www.europarl.europa.eu/doceo/document/TA-5-1999-0121_EN.html title: T5-0121/1999
summary
procedure/legal_basis/0
Rules of Procedure EP 142
procedure/legal_basis/0
Rules of Procedure EP 132
committees/0
type
Responsible Committee
body
EP
associated
False
committee_full
Citizens' Freedoms and Rights, Justice and Home Affairs
committee
LIBE
rapporteur
name: GIANNAKOU Marietta date: 1999-07-29T00:00:00 group: European People's Party (Christian Democrats) and European Democrats abbr: PPE-DE
committees/0
type
Responsible Committee
body
EP
associated
False
committee_full
Citizens' Freedoms and Rights, Justice and Home Affairs
committee
LIBE
date
1999-07-29T00:00:00
rapporteur
name: GIANNAKOU Marietta group: European People's Party (Christian Democrats) and European Democrats abbr: PPE-DE
committees/3
type
Committee Opinion
body
EP
associated
False
committee_full
Industry, External Trade, Research, Energy
committee
ITRE
rapporteur
name: CORBEY Dorette date: 1999-10-04T00:00:00 group: Party of European Socialists abbr: PES
committees/3
type
Committee Opinion
body
EP
associated
False
committee_full
Industry, External Trade, Research, Energy
committee
ITRE
date
1999-10-04T00:00:00
rapporteur
name: CORBEY Dorette group: Party of European Socialists abbr: PES
docs/4/docs/0/url
Old
http://www.europarl.europa.eu/sides/getDoc.do?type=REPORT&mode=XML&reference=A5-1999-63&language=EN
New
http://www.europarl.europa.eu/doceo/document/A-5-1999-0063_EN.html
docs/6
date
1999-11-19T00:00:00
docs
summary
type
Text adopted by Parliament, single reading
body
EP
docs/6
date
1999-11-19T00:00:00
docs
summary
type
Text adopted by Parliament, single reading
body
EP
docs/10/docs/0/url
Old
http://www.europarl.europa.eu/registre/docs_autres_institutions/commission_europeenne/com/2005/0045/COM_COM(2005)0045_EN.pdf
New
http://www.europarl.europa.eu/RegData/docs_autres_institutions/commission_europeenne/com/2005/0045/COM_COM(2005)0045_EN.pdf
docs/11/docs/0/url
Old
http://www.europarl.europa.eu/RegData/docs_autres_institutions/commission_europeenne/sec/2005/0216/COM_SEC(2005)0216_EN.pdf
New
http://www.europarl.europa.eu/registre/docs_autres_institutions/commission_europeenne/sec/2005/0216/COM_SEC(2005)0216_EN.pdf
events/4/docs/0/url
Old
http://www.europarl.europa.eu/sides/getDoc.do?type=REPORT&mode=XML&reference=A5-1999-63&language=EN
New
http://www.europarl.europa.eu/doceo/document/A-5-1999-0063_EN.html
events/6/docs/0/url
Old
http://www.europarl.europa.eu/sides/getDoc.do?type=TA&language=EN&reference=P5-TA-1999-121
New
http://www.europarl.europa.eu/doceo/document/TA-5-1999-0121_EN.html
activities
  • date: 1999-05-26T00:00:00 docs: url: http://eur-lex.europa.eu/smartapi/cgi/sga_doc?smartapi!celexplus!prod!DocNumber&lg=EN&type_doc=COMfinal&an_doc=1999&nu_doc=239 title: COM(1999)0239 type: Non-legislative basic document published celexid: CELEX:51999DC0239:EN body: EC commission: DG: url: http://ec.europa.eu/dgs/secretariat_general/index_en.htm title: Secretariat-General type: Non-legislative basic document published
  • date: 1999-09-13T00:00:00 body: EP type: Committee referral announced in Parliament, 1st reading/single reading committees: body: EP responsible: False committee_full: Foreign Affairs, Human Rights, Common Security, Defense committee: AFET body: EP responsible: False committee_full: Budgets committee: BUDG body: EP responsible: False committee_full: Development and Cooperation committee: DEVE body: EP responsible: False committee_full: Employment and Social Affairs committee: EMPL body: EP responsible: False committee: ITRE date: 1999-10-04T00:00:00 committee_full: Industry, External Trade, Research, Energy rapporteur: group: PSE name: CORBEY Dorette body: EP responsible: True committee: LIBE date: 1999-07-29T00:00:00 committee_full: Citizens' Freedoms and Rights, Justice and Home Affairs rapporteur: group: PPE-DE name: GIANNAKOU Marietta
  • body: CSL meeting_id: 2203 docs: url: http://register.consilium.europa.eu/content/out?lang=EN&typ=SET&i=SMPL&ROWSPP=25&RESULTSET=1&NRROWS=500&DOC_LANCD=EN&ORDERBY=DOC_DATE+DESC&CONTENTS=2203*&MEET_DATE=04/10/1999 type: Debate in Council title: 2203 council: Justice and Home Affairs (JHA) date: 1999-10-04T00:00:00 type: Council Meeting
  • body: EP committees: body: EP responsible: False committee_full: Foreign Affairs, Human Rights, Common Security, Defense committee: AFET body: EP responsible: False committee_full: Budgets committee: BUDG body: EP responsible: False committee_full: Development and Cooperation committee: DEVE body: EP responsible: False committee_full: Employment and Social Affairs committee: EMPL body: EP responsible: False committee: ITRE date: 1999-10-04T00:00:00 committee_full: Industry, External Trade, Research, Energy rapporteur: group: PSE name: CORBEY Dorette body: EP responsible: True committee: LIBE date: 1999-07-29T00:00:00 committee_full: Citizens' Freedoms and Rights, Justice and Home Affairs rapporteur: group: PPE-DE name: GIANNAKOU Marietta docs: url: http://www.europarl.europa.eu/sides/getDoc.do?type=REPORT&mode=XML&reference=A5-1999-63&language=EN type: Committee report tabled for plenary, single reading title: A5-0063/1999 date: 1999-11-15T00:00:00 type: Vote in committee, 1st reading/single reading
  • date: 1999-11-18T00:00:00 docs: url: http://www.europarl.europa.eu/sides/getDoc.do?secondRef=TOC&language=EN&reference=19991118&type=CRE type: Debate in Parliament title: Debate in Parliament body: EP type: Debate in Parliament
  • date: 1999-11-19T00:00:00 docs: url: http://www.europarl.europa.eu/sides/getDoc.do?type=TA&language=EN&reference=P5-TA-1999-121 type: Decision by Parliament, 1st reading/single reading title: T5-0121/1999 body: EP type: Decision by Parliament, 1st reading/single reading
  • date: 2000-07-07T00:00:00 type: Final act published in Official Journal
  • body: CSL meeting_id: 2337 docs: url: http://register.consilium.europa.eu/content/out?lang=EN&typ=SET&i=SMPL&ROWSPP=25&RESULTSET=1&NRROWS=500&DOC_LANCD=EN&ORDERBY=DOC_DATE+DESC&CONTENTS=2337*&MEET_DATE=15/03/2001 type: Debate in Council title: 2337 council: Justice and Home Affairs (JHA) date: 2001-03-15T00:00:00 type: Council Meeting
commission
  • body: EC dg: Secretariat-General commissioner: --
committees/0
type
Responsible Committee
body
EP
associated
False
committee_full
Citizens' Freedoms and Rights, Justice and Home Affairs
committee
LIBE
date
1999-07-29T00:00:00
rapporteur
name: GIANNAKOU Marietta group: European People's Party (Christian Democrats) and European Democrats abbr: PPE-DE
committees/0
body
EP
responsible
False
committee_full
Foreign Affairs, Human Rights, Common Security, Defense
committee
AFET
committees/1
type
Committee Opinion
body
EP
associated
False
committee_full
Foreign Affairs, Human Rights, Common Security, Defense
committee
AFET
opinion
False
committees/1
body
EP
responsible
False
committee_full
Budgets
committee
BUDG
committees/2
type
Committee Opinion
body
EP
associated
False
committee_full
Budgets
committee
BUDG
opinion
False
committees/2
body
EP
responsible
False
committee_full
Development and Cooperation
committee
DEVE
committees/3
type
Committee Opinion
body
EP
associated
False
committee_full
Industry, External Trade, Research, Energy
committee
ITRE
date
1999-10-04T00:00:00
rapporteur
name: CORBEY Dorette group: Party of European Socialists abbr: PES
committees/3
body
EP
responsible
False
committee_full
Employment and Social Affairs
committee
EMPL
committees/4
type
Committee Opinion
body
EP
associated
False
committee_full
Employment and Social Affairs
committee
EMPL
opinion
False
committees/4
body
EP
responsible
False
committee
ITRE
date
1999-10-04T00:00:00
committee_full
Industry, External Trade, Research, Energy
rapporteur
group: PSE name: CORBEY Dorette
committees/5
type
Committee Opinion
body
EP
associated
False
committee_full
Development and Cooperation
committee
DEVE
opinion
False
committees/5
body
EP
responsible
True
committee
LIBE
date
1999-07-29T00:00:00
committee_full
Citizens' Freedoms and Rights, Justice and Home Affairs
rapporteur
group: PPE-DE name: GIANNAKOU Marietta
council
  • body: CSL type: Council Meeting council: Justice and Home Affairs (JHA) meeting_id: 2337 url: http://register.consilium.europa.eu/content/out?lang=EN&typ=SET&i=SMPL&ROWSPP=25&RESULTSET=1&NRROWS=500&DOC_LANCD=EN&ORDERBY=DOC_DATE+DESC&CONTENTS=2337*&MEET_DATE=15/03/2001 date: 2001-03-15T00:00:00
  • body: CSL type: Council Meeting council: Justice and Home Affairs (JHA) meeting_id: 2203 url: http://register.consilium.europa.eu/content/out?lang=EN&typ=SET&i=SMPL&ROWSPP=25&RESULTSET=1&NRROWS=500&DOC_LANCD=EN&ORDERBY=DOC_DATE+DESC&CONTENTS=2203*&MEET_DATE=04/10/1999 date: 1999-10-04T00:00:00
docs
  • date: 1999-10-13T00:00:00 docs: title: PE231.809 type: Committee draft report body: EP
  • date: 1999-11-03T00:00:00 docs: title: PE231.699/DEF committee: ITRE type: Committee opinion body: EP
  • date: 1999-11-04T00:00:00 docs: title: PE231.809/AM type: Amendments tabled in committee body: EP
  • date: 1999-11-11T00:00:00 docs: title: PE231.809/AMC type: Amendments tabled in committee body: EP
  • date: 1999-11-15T00:00:00 docs: url: http://www.europarl.europa.eu/sides/getDoc.do?type=REPORT&mode=XML&reference=A5-1999-63&language=EN title: A5-0063/1999 url: https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=OJ:C:2000:189:TOC title: OJ C 189 07.07.2000, p. 0048 type: Committee report tabled for plenary, single reading body: EP
  • date: 1999-11-18T00:00:00 docs: url: https://dm.cor.europa.eu/CORDocumentSearch/Pages/redresults.aspx?k=(documenttype:AC)(documentnumber:0292)(documentyear:1999)(documentlanguage:EN) title: CDR0292/1999 url: https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=OJ:C:2000:057:TOC title: OJ C 057 29.02.2000, p. 0087 type: Committee of the Regions: opinion body: CofR
  • date: 1999-11-19T00:00:00 docs: url: http://www.europarl.europa.eu/sides/getDoc.do?type=TA&language=EN&reference=P5-TA-1999-121 title: T5-0121/1999 url: https://eur-lex.europa.eu/JOHtml.do?uri=OJ:C:2000:189:SOM:EN:HTML title: OJ C 189 07.07.2000, p. 0248-0256 summary: type: Text adopted by Parliament, single reading body: EP
  • date: 2001-06-08T00:00:00 docs: url: https://eur-lex.europa.eu/smartapi/cgi/sga_doc?smartapi!celexplus!prod!DocNumber&lg=EN&type_doc=COMfinal&an_doc=2001&nu_doc=301 title: EUR-Lex title: COM(2001)0301 summary: type: Follow-up document body: EC
  • date: 2002-11-04T00:00:00 docs: url: http://www.europarl.europa.eu/RegData/docs_autres_institutions/commission_europeenne/com/2002/0599/COM_COM(2002)0599_EN.pdf title: COM(2002)0599 url: https://eur-lex.europa.eu/smartapi/cgi/sga_doc?smartapi!celexplus!prod!DocNumber&lg=EN&type_doc=COMfinal&an_doc=2002&nu_doc=599 title: EUR-Lex summary: type: Follow-up document body: EC
  • date: 2004-10-22T00:00:00 docs: url: http://www.europarl.europa.eu/registre/docs_autres_institutions/commission_europeenne/com/2004/0707/COM_COM(2004)0707_EN.pdf title: COM(2004)0707 url: https://eur-lex.europa.eu/smartapi/cgi/sga_doc?smartapi!celexplus!prod!DocNumber&lg=EN&type_doc=COMfinal&an_doc=2004&nu_doc=707 title: EUR-Lex summary: Since 2000, the EU has adopted a Strategy and an Action Plan aimed at reducing both the demand for and supply of drugs in the European Union. This Communication presents the results of the final evaluation of the Strategy and Action Plan. As well as assessing the implementation of the Action Plan it also lays the foundation for the future EU drugs policy on the basis of what lessons have been learned from the present process. The actual evaluation of the Action Plan was undertaken in April 2003 and involved input from Commission representatives, Member States the EMCDDA and Europol. Drug policy impact evaluation is still in its infancy phase and the lack of precise and quantifiable operation objects does not make the task simple. Nevertheless certain trends have been identified, indicating which activities should be prioritised in the future. The evaluation process has established that around 95% of the actions set out in the EU plan on drugs have been implemented or are being implemented. Further, there can be little doubt that the implementation of the Action Plan has contributed to the achievement of the 11 aims specified in the EU Drugs Strategy. In terms of the target set for the reduction of drug use, the Communications notes that no strong evidence exists to suggest that drug use, especially amongst young people is decreasing. However, some of the data does point to evidence of a levelling off in the upward trend in drug use prevalence, - albeit that drug use is at historically high levels. Some of the results obtained from the evaluation process show that many of the EU targets set have acted as a catalyst for a number of EU level initiatives, which have strengthened law enforcement measures against drug trafficking and supply. Similarly, a number of important initiatives have been taken to combat money laundering with a number of Member States participating in important initiatives to combat the diversion of precursors, such as the European Joint Unit on Precursors. Regarding a future strategy, the Commission suggest that a future EU Drugs Strategy should contain clear and precise objectives and priorities, which are easily translated into operational indicators and actions. Responsibilities and deadlines for implementation should be clearly defined. Continued progress should be made regarding drug availability, quality and comparability. In order to create a smooth transition the European Commission will present, in the course of 2005, proposals for a new Action Plan, set to last from 2005-2008. The objectives of the new Drugs Strategy and Action Plan should be reflected in the Multi-annual Programme for the area of freedom, security and justice. type: Follow-up document body: EC
  • date: 2005-02-14T00:00:00 docs: url: http://www.europarl.europa.eu/registre/docs_autres_institutions/commission_europeenne/com/2005/0045/COM_COM(2005)0045_EN.pdf title: COM(2005)0045 url: https://eur-lex.europa.eu/smartapi/cgi/sga_doc?smartapi!celexplus!prod!DocNumber&lg=EN&type_doc=COMfinal&an_doc=2005&nu_doc=45 title: EUR-Lex summary: PURPOSE : to present the Commission’s EU Drugs Action Plan for 2005-2008 with a view to significantly reducing the prevalence of drug use among the EU population and to reduce the social harm and health damage it causes in societies. CONTENT : in December 2004, the European Council endorsed the EU Drug Strategy (2005-2012) which sets the framework, objectives and priorities for two consecutive four-year Action Plans to be brought forward by the Commission. This Strategy is an integral part of the multiannual programme “The Hague Programme” for strengthening freedom, security and justice in the EU which states that an optimal level of protection of the area of freedom, security and justice requires multi-disciplinary and concerted action both at EU level and national level. The current drugs situation in Europe can be summarised as follows: - increasing numbers demanding treatment for cocaine use; - signs of heavy cannabis use among teenagers; - increase in ecstasy consumption. The EU remains one of the world’s most important areas for the production of ecstasy; - 2.1 million problematic drug users in the EU25; - HIV/Aids is declining in some countries but the risk of epidemic spread remains high. Deep concern surrounds the continuing HIV epidemic in some of the new EU Member States and their bordering countries. This Action Plan transposes the general objectives contained in the EU Drugs Strategy 2005-2012 into concrete actions. These include general policy measures, specific programmes aimed at the prevention of drug use amongst young people, in the workplace and in recreational settings as well as measures for improving access to treatment programmes. A set of measurable assessment tools and indicators has been introduced for each action in order to enable proper evaluation. The Strategy has a number of major objectives: - to achieve a high level of health protection, well-being and social cohesion by complementing the Member States’ action in preventing and reducing drug use, dependence and drug-related harms to health and society; - with due regard for the EU’s achievements and values in terms of fundamental rights and freedoms, to ensure a high level of security for the general public by taking action against drugs production, cross-border trafficking in drugs and diversion of precursors and by intensifying preventive action against drug-related crime through effective cooperation embedded in a joint approach; - to strengthen the EU’s coordination mechanisms to ensure that action taken at national, regional and international levels is complementary and contributes to the effectiveness of drug policies within the EU and in its relations with other international partners. The latter calls for a more clearly identifiable European position in international fora such as the UN and its specialised agencies, reflecting the EU’s dominant position as a donor in this area. The Strategy concentrates on the two major dimensions of drugs policy, demand reduction and supply reduction. It also covers a number of cross-cutting themes: international cooperation, research, information and evaluation. The Action Plan proposed by the Commission takes account of its Final Evaluation of the EU Drug Strategy and EU Action Plan on Drugs (2000–2004) (refer to the summary of 22/10/2004). It targets in particular those areas that the evaluation highlighted as needing further progress. It reiterates a number of essential objectives that were not reached under the previous Action Plan. The Commission has also carried out an initial consultation of civil society on future policy through a dedicated web site. Such consultation will be significantly expanded by the Commission during the course of the Action Plan to include a wide range of representatives of civil society across the EU in a dialogue on how best to deal with drugs issues. Lastly, the Commission will carry out an impact assessment in 2008 in view of proposing a second Action Plan for 2009-2012. A final evaluation of the Strategy and the Action Plans will be carried out by the Commission in 2012. type: Follow-up document body: EC
  • date: 2005-02-14T00:00:00 docs: url: http://www.europarl.europa.eu/RegData/docs_autres_institutions/commission_europeenne/sec/2005/0216/COM_SEC(2005)0216_EN.pdf title: SEC(2005)0216 url: https://eur-lex.europa.eu/smartapi/cgi/sga_doc?smartapi!celexplus!prod!DocNumber&lg=EN&type_doc=SECfinal&an_doc=2005&nu_doc=216 title: EUR-Lex summary: COMMISSION’S IMPACT ASSESSMENT 1. PROBLEM IDENTIFICATION : The drugs phenomenon is one of the major concerns of European citizens. Tackling drugs is a top priority of the European Union in view of the high levels of drug misuse, trafficking, drug-related crime, health problems and social exclusion. Just under1% of the European adult population is considered to comprise problem drug-users. Moreover, drug consumption amongst young people has reached historically high levels. For more information regarding the context of this problem, please refer to the complementary summary of the Communication ( COM( 2005)0045) on an EU Drugs Action Plan (2005-2008). 2. OBJECTIVE : The ultimate aim of any EU action in the field of drugs is to significantly reduce the prevalence of drug use among the population and to reduce the social harm and health damage caused by the use of drugs, building on the outcome of the former EU Drugs Action Plan (2000-2004). 3. POLICY OPTIONS AND IMPACTS : In order to tackle the drugs issue in the EU and to achieve the objectives outlined above, several options are envisaged: 3.1 - Option A : Actions in the field of drugs are left exclusively to the Member States : drugs are a problem that knows no national boundaries. In the case that actions in the field of drugs were purely taken at national level, the fight against drugs would be as difficult as in the case of other global threats such as terrorism or organised crime. Moreover, the implementation of 25 national policies and strategies reflecting different complex social and cultural models would raise important difficulties for the freedom of movement of people and goods. This paper states that the drugs issue is a world-wide phenomenon which requires a coordinated and integrated approach. What is at stake here is the protection of the values of freedom, security and justice which are the very basis of European society. Therefore, the only way to deal with this is to create European added value. Due to the reasons outlined above, the European Council endorsed in 2000 an Action Plan providing a common framework for policymaking calling for a balanced, coordinated and integrated approach. 3.2 - Option B : The former Action Plan 2000-2004 is renewed for another 5 year period : the Action Plan 2000-2004 was divided into five sections: i ) co-ordination, ii) information and evaluation, iii) drug demand reduction and prevention of drug use and drug-related crime, iv) supply reduction and (v) international co-operation. The conclusions of the final evaluation on the EU Drugs Strategy and Action Plan on Drugs were presented by the Commission in October 2004: - a large part of the actions set out in the EU Action Plan on Drugs have been implemented or are in some stage of being implemented; - the EU Drugs Strategy and Action Plan have been taken as a central reference point for action and have provided a framework for drug-related activities and initiatives at national and EU level; - almost all Member States have adopted a national drugs strategy or action plan. Among the elements in these national drugs strategies and action plans, are common patterns with the EU approach, as outlined in the EU Drugs Strategy and Action Plan; - there can be little doubt that the implementation of the actions in the Action Plan has contributed to the achievement, to a greater or lesser extent, of the 11 aims of the EU Drugs Strategy; - the available information does not suggest that the availability of drugs has been reduced substantially; - a number of important initiatives have also been taken to combat money laundering. The final evaluation proposes that the future EU Drugs Strategy should contain clear and precise objectives and priorities that can be translated into operational indicators and actions in future Action Plans. 3.3 - Option C : a new Action Plan is presented, building on the main lessons from the final evaluation of the EU Action Plan 2000-2004 and in connection with the new Drugs Strategy 2005-2012: the new EU Strategy on Drugs 2005-2012 has two general aims that can be summed up as follows: the EU aims to achieve a high level of health protection, well-being and social cohesion by complementing the Member States’ action in preventing and reducing drug use, dependence and drug-related harm to health and society; the EU and its Member States aim to ensure a high level of security for the general public by taking action against drugs production, cross-border drug trafficking and by intensifying preventive action against drug-related crime, through effective cooperation embedded in a joint approach. Clear and measurable assessment tools and indicators have been introduced, to the extent possible, to enable proper evaluation. 3.4 - Option D : a EU policy on drugs is proposed: 71% of Europeans believe that decisions on drugs should be taken at EU level. EU added value is most visible on issues like the fight against drug trafficking, precursor control and action against money laundering. Given the absence of an overall legal basis for a common EU drugs policy and in view of national sensitivities in this matter, the main aim can only be to achieve a coordinated policy, with due regard to the principles of subsidiarity and proportionality. CONCLUSION : On the basis of lessons learned from the final evaluation, it was decided, in the draft Commission proposal, to discard options A, B and D and to present an improved new Action Plan (option C). 4. FOLLOW- UP : With a view to proposing a second Action Plan for the period 2009-2012, the Commission will organise an impact assessment in 2008. During 2009-2012, annual progress reviews will continue to be drawn up by the Commission. In 2012, the Commission will organise an overall evaluation of the EU Drugs Strategy and Action Plans. Moreover, the Commission launched, via the internet, an initial public consultation on the Action Plan which came to an end on 8 November 2004 which will be the subject of a Green Paper. type: Follow-up document body: EC
events
  • date: 1999-05-26T00:00:00 type: Non-legislative basic document published body: EC docs: url: https://eur-lex.europa.eu/smartapi/cgi/sga_doc?smartapi!celexplus!prod!DocNumber&lg=EN&type_doc=COMfinal&an_doc=1999&nu_doc=239 title: EUR-Lex title: COM(1999)0239 summary:
  • date: 1999-09-13T00:00:00 type: Committee referral announced in Parliament, 1st reading/single reading body: EP
  • date: 1999-10-04T00:00:00 type: Debate in Council body: CSL docs: url: http://register.consilium.europa.eu/content/out?lang=EN&typ=SET&i=SMPL&ROWSPP=25&RESULTSET=1&NRROWS=500&DOC_LANCD=EN&ORDERBY=DOC_DATE+DESC&CONTENTS=2203*&MEET_DATE=04/10/1999 title: 2203
  • date: 1999-11-15T00:00:00 type: Vote in committee, 1st reading/single reading body: EP summary:
  • date: 1999-11-15T00:00:00 type: Committee report tabled for plenary, single reading body: EP docs: url: http://www.europarl.europa.eu/sides/getDoc.do?type=REPORT&mode=XML&reference=A5-1999-63&language=EN title: A5-0063/1999
  • date: 1999-11-18T00:00:00 type: Debate in Parliament body: EP docs: url: http://www.europarl.europa.eu/sides/getDoc.do?secondRef=TOC&language=EN&reference=19991118&type=CRE title: Debate in Parliament
  • date: 1999-11-19T00:00:00 type: Decision by Parliament, 1st reading/single reading body: EP docs: url: http://www.europarl.europa.eu/sides/getDoc.do?type=TA&language=EN&reference=P5-TA-1999-121 title: T5-0121/1999 summary:
  • date: 1999-11-19T00:00:00 type: End of procedure in Parliament body: EP
  • date: 2000-07-07T00:00:00 type: Final act published in Official Journal
  • date: 2001-03-15T00:00:00 type: Debate in Council body: CSL docs: url: http://register.consilium.europa.eu/content/out?lang=EN&typ=SET&i=SMPL&ROWSPP=25&RESULTSET=1&NRROWS=500&DOC_LANCD=EN&ORDERBY=DOC_DATE+DESC&CONTENTS=2337*&MEET_DATE=15/03/2001 title: 2337
links
other
  • body: CSL type: Council Meeting council: Former Council configuration
  • body: EC dg: url: http://ec.europa.eu/dgs/secretariat_general/index_en.htm title: Secretariat-General
procedure/dossier_of_the_committee
Old
LIBE/4/11027
New
  • LIBE/4/11027
procedure/legal_basis/0
Rules of Procedure EP 132
procedure/legal_basis/0
Rules of Procedure of the European Parliament EP 132
procedure/subject
Old
  • 4.20.03 Drug addiction, alcoholism, smoking
  • 7.30.30.04 Action to combat drugs and drug-trafficking
New
4.20.03
Drug addiction, alcoholism, smoking
7.30.30.04
Action to combat drugs and drug-trafficking
activities/0/commission/0/DG/0/title
Old
Secretariat General
New
Secretariat-General
other/1/dg/0/title
Old
Secretariat General
New
Secretariat-General
activities
  • date: 1999-05-26T00:00:00 docs: url: http://eur-lex.europa.eu/smartapi/cgi/sga_doc?smartapi!celexplus!prod!DocNumber&lg=EN&type_doc=COMfinal&an_doc=1999&nu_doc=239 celexid: CELEX:51999DC0239:EN type: Non-legislative basic document published title: COM(1999)0239 type: Non-legislative basic document published body: EC commission: DG: url: http://ec.europa.eu/dgs/secretariat_general/index_en.htm title: Secretariat General
  • date: 1999-09-13T00:00:00 body: EP type: Committee referral announced in Parliament, 1st reading/single reading committees: body: EP responsible: False committee_full: Foreign Affairs, Human Rights, Common Security, Defense committee: AFET body: EP responsible: False committee_full: Budgets committee: BUDG body: EP responsible: False committee_full: Development and Cooperation committee: DEVE body: EP responsible: False committee_full: Employment and Social Affairs committee: EMPL body: EP responsible: False committee: ITRE date: 1999-10-04T00:00:00 committee_full: Industry, External Trade, Research, Energy rapporteur: group: PSE name: CORBEY Dorette body: EP responsible: True committee: LIBE date: 1999-07-29T00:00:00 committee_full: Citizens' Freedoms and Rights, Justice and Home Affairs rapporteur: group: PPE-DE name: GIANNAKOU Marietta
  • body: CSL meeting_id: 2203 docs: url: http://register.consilium.europa.eu/content/out?lang=EN&typ=SET&i=SMPL&ROWSPP=25&RESULTSET=1&NRROWS=500&DOC_LANCD=EN&ORDERBY=DOC_DATE+DESC&CONTENTS=2203*&MEET_DATE=04/10/1999 type: Debate in Council title: 2203 council: Justice and Home Affairs (JHA) date: 1999-10-04T00:00:00 type: Council Meeting
  • body: EP committees: body: EP responsible: False committee_full: Foreign Affairs, Human Rights, Common Security, Defense committee: AFET body: EP responsible: False committee_full: Budgets committee: BUDG body: EP responsible: False committee_full: Development and Cooperation committee: DEVE body: EP responsible: False committee_full: Employment and Social Affairs committee: EMPL body: EP responsible: False committee: ITRE date: 1999-10-04T00:00:00 committee_full: Industry, External Trade, Research, Energy rapporteur: group: PSE name: CORBEY Dorette body: EP responsible: True committee: LIBE date: 1999-07-29T00:00:00 committee_full: Citizens' Freedoms and Rights, Justice and Home Affairs rapporteur: group: PPE-DE name: GIANNAKOU Marietta docs: url: http://www.europarl.europa.eu/sides/getDoc.do?type=REPORT&mode=XML&reference=A5-1999-63&language=EN type: Committee report tabled for plenary, single reading title: A5-0063/1999 date: 1999-11-15T00:00:00 type: Vote in committee, 1st reading/single reading
  • date: 1999-11-18T00:00:00 docs: url: http://www.europarl.europa.eu/sides/getDoc.do?secondRef=TOC&language=EN&reference=19991118&type=CRE type: Debate in Parliament title: Debate in Parliament body: EP type: Debate in Parliament
  • date: 1999-11-19T00:00:00 docs: url: http://www.europarl.europa.eu/sides/getDoc.do?type=TA&language=EN&reference=P5-TA-1999-121 type: Decision by Parliament, 1st reading/single reading title: T5-0121/1999 body: EP type: Decision by Parliament, 1st reading/single reading
  • date: 2000-07-07T00:00:00 type: Final act published in Official Journal
  • body: CSL meeting_id: 2337 docs: url: http://register.consilium.europa.eu/content/out?lang=EN&typ=SET&i=SMPL&ROWSPP=25&RESULTSET=1&NRROWS=500&DOC_LANCD=EN&ORDERBY=DOC_DATE+DESC&CONTENTS=2337*&MEET_DATE=15/03/2001 type: Debate in Council title: 2337 council: Justice and Home Affairs (JHA) date: 2001-03-15T00:00:00 type: Council Meeting
committees
  • body: EP responsible: False committee_full: Foreign Affairs, Human Rights, Common Security, Defense committee: AFET
  • body: EP responsible: False committee_full: Budgets committee: BUDG
  • body: EP responsible: False committee_full: Development and Cooperation committee: DEVE
  • body: EP responsible: False committee_full: Employment and Social Affairs committee: EMPL
  • body: EP responsible: False committee: ITRE date: 1999-10-04T00:00:00 committee_full: Industry, External Trade, Research, Energy rapporteur: group: PSE name: CORBEY Dorette
  • body: EP responsible: True committee: LIBE date: 1999-07-29T00:00:00 committee_full: Citizens' Freedoms and Rights, Justice and Home Affairs rapporteur: group: PPE-DE name: GIANNAKOU Marietta
links
other
  • body: CSL type: Council Meeting council: Former Council configuration
  • body: EC dg: url: http://ec.europa.eu/dgs/secretariat_general/index_en.htm title: Secretariat General
procedure
dossier_of_the_committee
LIBE/4/11027
reference
1999/2095(COS)
title
Action to combat drugs: action plan 2000-2004
legal_basis
Rules of Procedure of the European Parliament EP 132
stage_reached
Procedure completed
subtype
Commission strategy paper
type
COS - Procedure on a strategy paper (historic)
subject